Literature DB >> 20513137

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.

Eric Pasmant1, Audrey Sabbagh, Gill Spurlock, Ingrid Laurendeau, Elisa Grillo, Marie-José Hamel, Ludovic Martin, Sébastien Barbarot, Bruno Leheup, Diana Rodriguez, Didier Lacombe, Hélène Dollfus, Laurent Pasquier, Bertrand Isidor, Salah Ferkal, Jean Soulier, Marc Sanson, Anne Dieux-Coeslier, Ivan Bièche, Béatrice Parfait, Michel Vidaud, Pierre Wolkenstein, Meena Upadhyaya, Dominique Vidaud.   

Abstract

In 5-10% of patients, neurofibromatosis type 1 (NF1) results from microdeletions that encompass the entire NF1 gene and a variable number of flanking genes. Two recurrent microdeletion types are found in most cases, with microdeletion breakpoints located in paralogous regions flanking NF1 (proximal NF1-REP-a and distal NF1-REP-c for the 1.4 Mb type-1 microdeletion, and SUZ12 and SUZ12P for the 1.2 Mb type-2 microdeletion). A more severe phenotype is usually associated with NF1 microdeletion patients than in those with intragenic mutations. We characterized NF1 microdeletions in 70 unrelated NF1 microdeleted patients using a high-resolution NF1 custom array comparative genomic hybridization (CGH). Genotype-phenotype correlations were studied in 58 of these microdeletion patients and compared to 389 patients with intragenic truncating NF1 mutations and phenotyped in the same standardized way. Our results confirmed in an unbiased manner the existence of a contiguous gene syndrome with a significantly higher incidence of learning disabilities and facial dysmorphism in microdeleted patients compared to patients with intragenic NF1 mutations. Microdeleted NF1 patients also showed a trend toward significance for childhood overgrowth. High-resolution array-CGH identified a new recurrent approximately 1.0 Mb microdeletion type, designated as type-3, with breakpoints in the paralogous regions middle NF1-REP-b and distal NF1-REP-c.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513137     DOI: 10.1002/humu.21271

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  77 in total

1.  Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Authors:  Luca Ferrari; Giulietta Scuvera; Arianna Tucci; Donatella Bianchessi; Francesco Rusconi; Francesca Menni; Elena Battaglioli; Donatella Milani; Paola Riva
Journal:  Hum Genet       Date:  2017-08-03       Impact factor: 4.132

Review 2.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

3.  Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype.

Authors:  Yunus Kasim Terzi; Burcu Sirin; Guzen Hosgor; Esra Serdaroglu; Banu Anlar; Sabiha Aysun; Sukriye Ayter
Journal:  Childs Nerv Syst       Date:  2011-12-09       Impact factor: 1.475

Review 4.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

Review 5.  The NF1 somatic mutational landscape in sporadic human cancers.

Authors:  Charlotte Philpott; Hannah Tovell; Ian M Frayling; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2017-06-21       Impact factor: 4.639

6.  Pronounced maternal parent-of-origin bias for type-1 NF1 microdeletions.

Authors:  Lisa Neuhäusler; Anna Summerer; David N Cooper; Victor-F Mautner; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2018-05-05       Impact factor: 4.132

7.  Extreme clustering of type-1 NF1 deletion breakpoints co-locating with G-quadruplex forming sequences.

Authors:  Anna Summerer; Victor-Felix Mautner; Meena Upadhyaya; Kathleen B M Claes; Josef Högel; David N Cooper; Ludwine Messiaen; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2018-07-10       Impact factor: 4.132

8.  NF1 single and multi-exons copy number variations in neurofibromatosis type 1.

Authors:  Apolline Imbard; Eric Pasmant; Audrey Sabbagh; Armelle Luscan; Magali Soares; Philippe Goussard; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanne-Chantelot; Dominique Vidaud; Pierre Wolkenstein; Béatrice Parfait
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

9.  Fine mapping of whole RB1 gene deletions in retinoblastoma patients confirms PCDH8 as a candidate gene for psychomotor delay.

Authors:  Laurent Castéra; Catherine Dehainault; Dorothée Michaux; Livia Lumbroso-Le Rouic; Isabelle Aerts; Francois Doz; Anna Pelet; Jérôme Couturier; Dominique Stoppa-Lyonnet; Marion Gauthier-Villars; Claude Houdayer
Journal:  Eur J Hum Genet       Date:  2012-08-22       Impact factor: 4.246

10.  Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis.

Authors:  German Melean; Alba Marina Hernández; María Carmen Valero; Elisabete Hernández-Imaz; Yolanda Martín; Concepción Hernández-Chico
Journal:  BMC Cancer       Date:  2010-08-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.